Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,596 | -26,895 | -17,732 | -10,784 | -4,832 |
| Depreciation Amortization | 52 | 190 | 136 | 86 | 40 |
| Other Working Capital | 1,256 | -417 | 340 | 531 | -647 |
| Other Operating Activity | 5,541 | 1,371 | 1,152 | 666 | 361 |
| Operating Cash Flow | $-12,747 | $-25,751 | $-16,104 | $-9,501 | $-5,078 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 154 | 8,898 | 13,905 | 4,400 | 4,879 |
| PPE Investments | -526 | -963 | -681 | -330 | -141 |
| Purchase Of Investment | -3 | -21,270 | -16,753 | -7,116 | -6,605 |
| Sale Of Investment | 2 | 185 | 158 | N/A | 96 |
| Other Investing Activity | 27 | -23 | -4 | -4 | 0 |
| Investing Cash Flow | $-346 | $-13,173 | $-3,375 | $-3,050 | $-1,771 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 83,944 | 77,400 | 77,000 | 335 | 243 |
| Financing Cash Flow | $83,944 | $77,400 | $77,000 | $335 | $243 |
| Beginning Cash Position | 68,175 | 29,699 | 29,699 | 29,699 | 29,699 |
| End Cash Position | 139,026 | 68,175 | 87,220 | 17,483 | 23,093 |
| Net Cash Flow | $70,851 | $38,476 | $57,521 | $-12,216 | $-6,606 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,747 | -25,751 | -16,104 | -9,501 | -5,078 |
| Capital Expenditure | -526 | -964 | -682 | -330 | -141 |
| Free Cash Flow | -13,273 | -26,715 | -16,786 | -9,831 | -5,219 |